cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.5281/zenodo.18508885
title: Data and code for: The Coevolution of Technology and Policy

description: This dataset contains the data and code to reproduce all empirical and computational results in the manuscript "The Coevolution of Technology and Policy" (Stauffer, 2026, submitted to Science Advances).
The study introduces an empirical-mechanistic framework that constructs domain-specific technology and policy indices (2002-2024) using moving dynamic principal component analysis (mDPCA) and calibrates an agent-based model via Approximate Bayesian Computation (ABC) to reproduce observed process signatures across four technology domains: renewable energy, electric vehicles, information and communication technology, and artificial intelligence.
Contents:

Data/ - Domain-specific datasets (renewables, EV, ICT, AI) as ZIP archives containing processed CSV files
Code/ - Python scripts for index construction (mDPCA), acceleration/extreme-event analysis, higher-order interactions, and ABM pipeline (ABC calibration + validation)
README.md - Full reproduction instructions
Simulations are fully reproducible through seeded random number generation (Python >= 3.10).
description: Related manuscript: Stauffer, M. (2026). The Coevolution of Technology and Policy. Science Advances (submitted).
DOI: 10.5281/zenodo.18508886
title: Data and code for: The Coevolution of Technology and Policy

description: This dataset contains the data and code to reproduce all empirical and computational results in the manuscript "The Coevolution of Technology and Policy" (Stauffer, 2026, submitted to Science Advances).
The study introduces an empirical-mechanistic framework that constructs domain-specific technology and policy indices (2002-2024) using moving dynamic principal component analysis (mDPCA) and calibrates an agent-based model via Approximate Bayesian Computation (ABC) to reproduce observed process signatures across four technology domains: renewable energy, electric vehicles, information and communication technology, and artificial intelligence.
Contents:

Data/ - Domain-specific datasets (renewables, EV, ICT, AI) as ZIP archives containing processed CSV files
Code/ - Python scripts for index construction (mDPCA), acceleration/extreme-event analysis, higher-order interactions, and ABM pipeline (ABC calibration + validation)
README.md - Full reproduction instructions
Simulations are fully reproducible through seeded random number generation (Python >= 3.10).
description: Related manuscript: Stauffer, M. (2026). The Coevolution of Technology and Policy. Science Advances (submitted).
DOI: 10.25934/00007284
title: A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults

description: This study is an adaptive, randomized, double-blind, placebo-controlled trial to evaluate the safety and efficacy of novel therapeutic agents in hospitalized adults diagnosed with COVID-19. The study is a multicenter trial that will be conducted in up to approximately 100 sites globally. The study will compare different investigational therapeutic agents to a control arm. There will be interim monitoring to introduce new arms and allow early stopping for futility, efficacy, or safety. If one therapy proves to be efficacious, then this treatment may become the control arm for comparison(s) with new experimental treatment(s). Any such change would be accompanied by an updated sample size. Because background standards of supportive care may evolve/improve over time as more is learned about successful management of COVID-19, comparisons of safety and efficacy will be based on data from concurrently randomized subjects. An independent Data and Safety Monitoring Board (DSMB) will actively monitor interim data to make recommendations about early study closure or changes to study arms. To evaluate the clinical efficacy, as assessed by time to recovery, of different investigational therapeutics as compared to the control arm.
DOI: 10.15468/dl.p2awz9
title: Occurrence Download

description: A dataset containing 130 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Country is United Kingdom of Great Britain and Northern Ireland",
 "DatasetKey is Happywhale - Humpback whale in North Atlantic Ocean"
 ]
}

 The dataset includes 130 records from 1 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0016876-260129131611470/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.25934/00007285
title: A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults (ACTT-2)

description: ACTT-2 will evaluate the combination of baricitinib and remdesivir compared to remdesivir alone. Subjects will be assessed daily while hospitalized. If the subjects are discharged from the hospital, they will have a study visit at Days 15, 22, and 29. For discharged subjects, it is preferred that the Day 15 and 29 visits are in person to obtain safety laboratory tests and oropharyngeal (OP) swab and blood (serum only) samples for secondary research as well as clinical outcome data. However, infection control or other restrictions may limit the ability of the subject to return to the clinic. In this case, these visits may be conducted by phone, and only clinical data will be obtained. The Day 22 visit does not have laboratory tests or collection of samples and is conducted by phone. The primary outcome is time to recovery by Day 29.
DOI: 10.25934/pr00009428
title: Randomized Master Protocol for Immune Modulators for Treating COVID-19

description: ACTIV-1 IM is a master protocol designed to evaluate multiple investigational agents for the treatment of moderately or severely ill patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The research objectives are to evaluate each agent with respect to speed of recovery, mortality, illness severity, and hospital resource utilization. Each agent will be evaluated as add-on therapy to the standard of care (SoC) in use at the local clinics, including remdesivir (provided). The SoC may change during the course of the study based on other research findings. Comparisons of the agents among themselves is not a research objective. The study population corresponds to moderately and severely ill patients infected with the coronavirus disease 2019 (COVID-19) virus. Recruitment will target patients already hospitalized for treatment of COVID-19 infection as well as patients being treated for COVID-19 infection in Emergency Departments while waiting to be admitted to the hospital. Patients both in and out of the ICU are included in the study population.
DOI: 10.25934/pr00009429
title: A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults (ACTT-3)

description: ACTT-3 will evaluate the combination of interferon beta-1a and remdesivir compared to remdesivir alone. Subjects will be assessed daily while hospitalized. If the subjects are discharged from the hospital, they will have a study visit at Days 15, 22, and 29. For discharged subjects, it is preferred that the Day 15 and 29 visits are in person to obtain safety laboratory tests and oropharyngeal (OP) swab and blood (serum only) samples for secondary research as well as clinical outcome data. However, infection control or other restrictions may limit the ability of the subject to return to the clinic. In this case, these visits may be conducted by phone, and only clinical data will be obtained. The Day 22 visit does not have laboratory tests or collection of samples and is conducted by phone. The primary outcome is time to recovery by Day 29.
DOI: 10.25934/pr00009430
title: A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults (ACTT-4)

description: ACTT-4 will evaluate the combination of baricitinib and remdesivir compared to dexamethasone and remdesivir. Subjects will be assessed daily while hospitalized. If the subjects are discharged from the hospital, they will have a study visit at Days 15, 22, and 29. For discharged subjects, it is preferred that the Day 15 and 29 visits are in person to obtain safety laboratory tests, oropharyngeal (OP) swabs, plasma (Day 29), and serum for secondary research as well as clinical outcome data. However, if infection control or other restrictions limit the ability of the subject to return to the clinic, these visits may be conducted by phone, and only clinical data will be obtained. The Day 22 visit does not have laboratory tests or collection of samples and is conducted by phone. The primary objective is to evaluate the clinical efficacy of baricitinib + remdesivir versus dexamethasone + remdesivir as assessed by the mechanical ventilation free survival by Day 29.
DOI: 10.25934/pr00009431
title: Phase I, Open-Label, Dose-Ranging Study of the Safety and Immunogenicity of 2019-nCoV Vaccine (mRNA-1273) in Healthy Adults

description: This is a phase I, open-label, dose-ranging clinical trial in males and non-pregnant females, starting at 18 years of age, inclusive, who are in good health and meet all eligibility criteria. This clinical trial is designed to assess the safety, reactogenicity and immunogenicity of mRNA-1273 manufactured by ModernaTX, Inc. mRNA-1273 is a novel lipid nanoparticle (LNP)-encapsulated mRNA-based vaccine that encodes for a full-length, prefusion stabilized spike (S) protein of SARS-CoV-2. Enrollment will occur at up to 3 domestic clinical research sites. Up to one hundred and fifty-five subjects will be enrolled into one of thirteen cohorts (10 micrograms [mcg], 25 mcg, 50 mcg, 100 mcg, and 250 mcg). Subjects will receive an intramuscular (IM) injection (0.5 milliliters [mL]) of mRNA-1273 on Days 1 and 29 in the deltoid muscle and will be followed through 12 months post second vaccination (Day 394). Follow-up visits will occur 1, 2, and 4 weeks post each vaccination (Days 8, 15, 29, 36, 43, and 57), as well as 3, 6, and 12 months post second vaccination (Days 119, 209, and 394). The primary objective is to evaluate the safety and reactogenicity of a 2-dose vaccination schedule of mRNA-1273, given 28 days apart, across 5 dosages in healthy adults. Optional Substudy: This is an optional third mRNA-1273 vaccination substudy, in subjects 18 years of age and older, who received both the first and second mRNA-1273 vaccinations in the main study and meet all other substudy eligibility criteria. This optional third mRNA-1273 vaccination substudy is designed to assess safety, reactogenicity, and immunogenicity through 12 months post third vaccination (Day 731). Subjects who receive the third mRNA-1273 vaccination will exit the Schedule of Activities for the main study and will enter the Schedule of Activities for the optional substudy. Up to one hundred and twenty subject will be enrolled into two cohorts (consisting of participating subjects who received 2 doses of 25 or 50 mcg and participating subjects who received 2 doses of 100 and 250 mcg). Subjects will receive an IM injection (0.5 mL) at a dosage of 100 mcg/0.5 mL. The primary objective is to evaluate the safety and reactogenicity of a third mRNA-1273 vaccination, at a dosage of 100 mcg.
DOI: 10.25934/pr00009432
title: A Prospective Cohort Study to Assess Longitudinal Immune Responses in Hospitalized Patients With COVID-19 (DAIT-COVID-19-002)

description: This surveillance study will collect detailed clinical, laboratory, and radiographic data in coordination with biologic sampling of blood and respiratory secretions and viral shedding in nasal secretions in order to identify immunophenotypic and genomic features of COVID-19 -related susceptibility and/or progression. The aim: for the results obtained from this study to assist in generating hypotheses for effective host-directed therapeutic interventions, to help to prioritize proposals for such interventions, and/or optimize timing for administration of host-response directed therapeutics.
DOI: 10.15468/dl.db3pa8
title: Occurrence Download

description: A dataset containing 0 species occurrences available in GBIF matching the query:
{
 "and" : [
 "HasGeospatialIssue is false",
 "Geometry POLYGON ((-26.86550360474032 -89.99999960621956, -26.866862381054304 -89.99999960620936, -26.868485184224387 -89.99999960620114, -26.870309382187475 -89.99999960619529, -26.872265195850773 -89.99999960619198, -26.874277266794223 -89.99999960619135, -26.876268560144112 -89.99999960619344, -26.878162342370384 -89.99999960619814, -26.87988581640456 -89.99999960620531, -26.88137299420947 -89.99999960621464, -26.882566466683766 -89.9999996062258, -26.883420735297776 -89.99999960623833, -26.88390263256767 -89.99999960625178, -26.883993823407643 -89.99999960626562, -26.883690487034983 -89.9999996062793, -26.883004284871305 -89.99999960629232, -26.881961829718833 -89.99999960630417, -26.880603117734974 -89.99999960631438, -26.878980100316888 -89.99999960632258, -26.87715544181965 -89.99999960632844, -26.87519899166234 -89.99999960633176, -26.873186204996518 -89.99999960633238, -26.87119422558286 -89.9999996063303, -26.869299891502383 -89.99999960632559, -26.867576083961684 -89.99999960631843, -26.866088841501195 -89.99999960630909, -26.864895583647687 -89.99999960629792, -26.8640417752155 -89.99999960628539, -26.863560514623693 -89.99999960627194, -26.863470039194407 -89.99999960625811, -26.863774061720196 -89.99999960624443, -26.864460816069975 -89.9999996062314, -26.86550360474032 -89.99999960621956))",
 "KingdomKey is one of (Animalia, Fungi, Plantae)",
 "Year is one of (2016, 2017, 2018, 2019, 2020, 2021, 2022, 2023, 2024, 2025, 2026)",
 "Modified is greater than or equal to 2026-02-06"
 ]
}

 The dataset includes 0 records from 0 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0016877-260129131611470/datasets/export for details.
DOI: 10.15468/dl.cg2v4q
title: Occurrence Download

description: A dataset containing 2750468 records in GBIF matching the query:

 SELECT gbifid, datasetkey, specieskey, kingdom, phylum, class, "order", family, genus, species, scientificname, decimallatitude, decimallongitude, eventdate, institutioncode, "year" AS obs_year, basisofrecord, coordinateuncertaintyinmeters, issue
 FROM occurrence
 WHERE
 decimallatitude IS NOT NULL
 AND decimallongitude IS NOT NULL
 AND NOT ARRAY_CONTAINS(issue, 'ZERO_COORDINATE')
 AND NOT ARRAY_CONTAINS(issue, 'COORDINATE_OUT_OF_RANGE')
 AND NOT ARRAY_CONTAINS(issue, 'COORDINATE_INVALID')
 AND NOT ARRAY_CONTAINS(issue, 'COUNTRY_COORDINATE_MISMATCH')
 AND "year" &gt;= 2015
 AND "year" &lt;= 2026
 AND coordinateuncertaintyinmeters IS NOT NULL
 AND coordinateuncertaintyinmeters &gt; 0
 AND coordinateuncertaintyinmeters &lt;= 200.0
 AND decimallatitude &gt;= -33.06103686093294
 AND decimallatitude &lt;= -28.773895969281842
 AND decimallongitude &gt;= 146.15102397859218
 AND decimallongitude &lt;= 155.85126321428865
 AND GBIF_Within('POLYGON ((155.851263 -33.061037, 155.851263 -28.773896, 146.151024 -28.773896, 146.151024 -33.061037, 155.851263 -33.061037))', decimallatitude, decimallongitude) = TRUE
 

 The dataset's 2750468 records were derived from 66 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0016855-260129131611470/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.5281/zenodo.18508901
title: Rewiring Regional Resilience: The Moroccan Atlantic Initiative and the Geoeconomics of Connectivity in West Africa

description: In a context of overlapping global crises and reconfigured global value chains, West Africa remains highly vulnerable to external shocks and constrained by structural connectivity deficits. This article analyzes the Moroccan Atlantic Initiative through a geoeconomic and resilience-oriented lens, assessing its capacity to address logistical asymmetries and fragmented regional integration. Moving beyond ideological readings, the Initiative is conceptualized as a pragmatic South–South cooperation model based on the provision of regional public goods. By prioritizing shared infrastructure, energy interdependence, and digital connectivity, the study examines its potential to restructure regional value chains and strengthen collective sovereignty. Drawing on theories of economic resilience, regional public goods, and economic geography, the analysis argues that the Initiative transforms structural vulnerabilities into drivers of adaptive regional integration. It concludes that the Moroccan Atlantic Initiative represents an innovative, infrastructure-led regionalism that complements continental frameworks while advancing Africa’s role as an active agent in global economic transformation.
DOI: 10.5281/zenodo.18508900
title: Rewiring Regional Resilience: The Moroccan Atlantic Initiative and the Geoeconomics of Connectivity in West Africa

description: In a context of overlapping global crises and reconfigured global value chains, West Africa remains highly vulnerable to external shocks and constrained by structural connectivity deficits. This article analyzes the Moroccan Atlantic Initiative through a geoeconomic and resilience-oriented lens, assessing its capacity to address logistical asymmetries and fragmented regional integration. Moving beyond ideological readings, the Initiative is conceptualized as a pragmatic South–South cooperation model based on the provision of regional public goods. By prioritizing shared infrastructure, energy interdependence, and digital connectivity, the study examines its potential to restructure regional value chains and strengthen collective sovereignty. Drawing on theories of economic resilience, regional public goods, and economic geography, the analysis argues that the Initiative transforms structural vulnerabilities into drivers of adaptive regional integration. It concludes that the Moroccan Atlantic Initiative represents an innovative, infrastructure-led regionalism that complements continental frameworks while advancing Africa’s role as an active agent in global economic transformation.
DOI: 10.15468/dl.j5t8hr
title: Occurrence Download

description: A dataset containing 0 species occurrences available in GBIF matching the query:
{
 "and" : [
 "HasGeospatialIssue is false",
 "Geometry POLYGON ((-26.86447566461795 -89.99999964996826, -26.86600446968951 -89.99999964995804, -26.867829996919056 -89.99999964994983, -26.86988205169494 -89.99999964994397, -26.872082142670497 -89.99999964994066, -26.87434550446695 -89.99999964994005, -26.87658522731563 -89.99999964994214, -26.878715519133692 -89.99999964994684, -26.880654236350658 -89.99999964995402, -26.88232715233934 -89.99999964996334, -26.883669947720243 -89.99999964997448, -26.884630921184932 -89.99999964998703, -26.88517301779809 -89.99999965000046, -26.885275347778332 -89.9999996500143, -26.884934384741932 -89.99999965002799, -26.884162722715192 -89.999999650041, -26.88299003513528 -89.99999965005284, -26.88146131207607 -89.99999965006307, -26.8796355136932 -89.99999965007127, -26.877582876083437 -89.99999965007713, -26.8753819795469 -89.99999965008045, -26.87311771195694 -89.99999965008108, -26.870877121087837 -89.99999965007898, -26.86874613093359 -89.99999965007427, -26.866806991783506 -89.9999996500671, -26.865133994098684 -89.99999965005776, -26.863791469576853 -89.9999996500466, -26.86283107863886 -89.99999965003408, -26.862289787726603 -89.99999965002063, -26.862188364048023 -89.99999965000679, -26.86253019467586 -89.99999964999311, -26.863302554864493 -89.99999964998011, -26.86447566461795 -89.99999964996826))",
 "KingdomKey is one of (Animalia, Fungi, Plantae)",
 "Year is one of (2016, 2017, 2018, 2019, 2020, 2021, 2022, 2023, 2024, 2025, 2026)",
 "Modified is greater than or equal to 2026-02-06"
 ]
}

 The dataset includes 0 records from 0 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0016878-260129131611470/datasets/export for details.
DOI: 10.15468/dl.x4774n
title: Occurrence Download

description: A dataset containing 2535 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is one of (Melampyrum cristatum, Melampyrum cristatum, Melampyrum cristatum)",
 "Year is greater than or equal to 1900",
 "Geometry POLYGON ((8.643 46.99, 14.1 46.92, 14.43 50.75, 8.534 50.83, 8.643 46.99))",
 "HasGeospatialIssue is false",
 "HasCoordinate is true",
 "OccurrenceStatus is Present",
 "BasisOfRecord is one of (Observation, Human Observation, Machine Observation, Material sample)"
 ]
}

 The dataset includes 2535 records from 13 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0016879-260129131611470/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.8g8shm
title: Occurrence Download

description: A dataset containing 970 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Ambystoma mexicanum"
 ]
}

 The dataset includes 970 records from 69 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0016880-260129131611470/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.7pb8dj
title: Occurrence Download

description: A dataset containing 3659668 species occurrences available in GBIF matching the query:
{
 "and" : [
 {
 "or" : [
 "Geometry POLYGON((-81.9 24.8, -80.2 24.8, -80.2 25.9, -81.9 25.9, -81.9 24.8))",
 "Geometry POLYGON((89.03 21.4, 90.00 21.46, 90.01 22.51, 89.04 22.50, 89.03 21.4))"
 ]
 },
 "HasGeospatialIssue is false",
 "HasCoordinate is true",
 "OccurrenceStatus is Present",
 {
 "not" : {
 "BasisOfRecord" : [
 "is one of (Fossil, Living Specimen)"
 ]
 }
 },
 "TaxonKey is one of (Aves, Mammalia, Amphibia, Squamata, Arthropoda)"
 ]
}

 The dataset includes 3659668 records from 322 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0016777-260129131611470/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.qstrph
title: Occurrence Download

description: A dataset containing 3194 species occurrences available in GBIF matching the query:
{
 "and" : [
 "GadmGid is CHN.2_1",
 "OccurrenceStatus is Present",
 "TaxonKey is Anas platyrhynchos",
 "Year is 2022"
 ]
}

 The dataset includes 3194 records from 2 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0016881-260129131611470/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.qje8ut
title: Occurrence Download

description: A dataset containing 1 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Geometry POLYGON((-71.21807 -28.46429,-71.14747 -28.46429,-71.14747 -28.43606,-71.21807 -28.43606,-71.21807 -28.46429))",
 "HasCoordinate is true",
 "HasGeospatialIssue is false",
 "OccurrenceStatus is Present",
 "TaxonKey is Galaxias maculatus"
 ]
}

 The dataset includes 1 records from 1 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0016882-260129131611470/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.